A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease
Author:
Funder
National Natural Science Foundation of China
Zunyi City Science and Technology Plan of China
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference137 articles.
1. The future burden of CKD in the United States: a simulation model for the CDC CKD initiative;Hoerger;Am. J. Kidney Diseases,2015
2. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey;Duan;BMC Nephrol.,2020
3. Expert consensus on the rational application of Shenkang preparation (Shenkang injection, Shenkang suppository) in the treatment of chronic kidney disease;Chen;Chin. J. Integr. Tradit. Western Med.,2019
4. Effects of Shenkang injection on chronic renal failure: a meta-analysis;Lian;Chin. Tradit. Pat. Med. (in Chinese),2015
5. Chemical profiling and quantification of ShenKang injection, a systematic quality control strategy using ultra high performance liquid chromatography with Q Exactive hybrid quadrupole orbitrap high-resolution accurate mass spectrometry;Xu;J. Sep. Sci.,2017
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis;Biomolecules;2024-07-28
2. Visualization Analysis of Shenkang Injection based on CiteSpace Study;Journal of Contemporary Medical Practice;2024-06-30
3. Renal Metabolomics Study and Critical Pathway Validation of Shenkang Injection in the Treatment of Chronic Renal Failure;Biological and Pharmaceutical Bulletin;2024-02-22
4. Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology—Molecular docking—Key target validation";PLOS ONE;2023-10-05
5. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway;Phytomedicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3